JW Shinyak Corp. | Cash Flow

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
3,068
553
227
499
6,084
Depreciation, Depletion & Amortization
2,657
2,676
2,732
2,120
2,177
Other Funds
1,224
64
2,367
5,223
1,400
Funds from Operations
814
2,059
5,326
6,844
2,507
Changes in Working Capital
6,097
4,366
5,348
6,101
11
Net Operating Cash Flow
5,283
2,307
22
743
2,496
Capital Expenditures
1,933
1,888
1,881
2,135
4,167
Sale of Fixed Assets & Businesses
18
12
13
5
-
Purchase/Sale of Investments
79
4,382
1,180
13,612
10,410
Net Investing Cash Flow
11,820
3,020
2,961
11,430
8,576
Cash Dividends Paid - Total
888
915
1,130
1,940
2,328
Issuance/Reduction of Debt, Net
18,445
6,234
1,367
13,072
5,301
Net Financing Cash Flow
17,530
5,301
2,518
11,132
6,763
Net Change in Cash
426
25
421
445
683
Free Cash Flow
5,722
3,176
992
153
3,746
Other Sources
1,951
22,437
6,091
4,467
2,628
Change in Capital Stock
27
18
21
-
866
Other Uses
11,936
19,200
83
155
295

About JW Shinyak

View Profile
Address
2477 Nambusunhwan-ro
Seoul SL 06725
Korea, Republic Of
Employees -
Website http://www.jw-shinyak.co.kr
Updated 09/14/2018
JW SHINYAK Corp. engages in the manufacture and sale of pharmaceutical products. Its products include hair solvent, steroid hormone, antibiotics, integument solvent, medicines of sense organ, and antifungals. The company was founded in 1975 and is headquartered in Seoul, South Korea.